SPY424.48-0.78 -0.18%
DIA343.41-0.89 -0.26%
IXIC14,072.86-101.29 -0.71%

BRIEF-Syndax Pharmaceuticals Reports First Quarter 2021 Financial Results And Provides Clinical And Business Update

05/11/2021 16:41
BRIEF-Syndax Pharmaceuticals Reports First Quarter 2021 Financial Results And Provides Clinical And Business Update

- Syndax Pharmaceuticals Inc SNDX.O:

  • SYNDAX PHARMACEUTICALS REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND PROVIDES CLINICAL AND BUSINESS UPDATE

  • Q1 LOSS PER SHARE $0.54

  • Q1 EARNINGS PER SHARE ESTIMATE $-0.65 -- REFINITIV IBES DATA

  • ON TRACK TO INITIATE PIVOTAL PHASE 2 PORTION OF AUGMENT-101 TRIAL IN 2Q21

Source text for Eikon: ID:nPn29bCbva

Further company coverage: SNDX.O


(([email protected];))